Steven Seedhouse
Stock Analyst at Cantor Fitzgerald
(4.57)
# 987
Out of 4,994 analysts
324
Total ratings
45.2%
Success rate
11.8%
Average return
Main Sectors:
Stocks Rated by Steven Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRD Opus Genetics | Reiterated: Buy | $15 | $5.16 | +190.70% | 6 | Sep 10, 2026 | |
| PHVS Pharvaris | Reiterated: Buy | $46 → $65 | $35.20 | +84.66% | 7 | Sep 9, 2026 | |
| INVA Innoviva | Reiterated: Buy | $34 | $20.98 | +62.06% | 7 | Aug 20, 2026 | |
| EYPT EyePoint | Downgraded: Hold | n/a | $4.07 | - | 3 | Aug 17, 2026 | |
| BLTE Belite Bio | Reiterated: Buy | $266 → $270 | $175.35 | +53.98% | 4 | Aug 14, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | $7 | $4.15 | +68.67% | 8 | Aug 14, 2026 | |
| EQ Equillium | Reiterated: Buy | $10 | $1.93 | +418.13% | 2 | Aug 14, 2026 | |
| PRQR ProQR Therapeutics | Reiterated: Buy | $8 | $1.90 | +321.05% | 12 | Aug 14, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $100 | $40.85 | +144.80% | 35 | Aug 14, 2026 | |
| HROW Harrow | Reiterated: Buy | $88 | $34.45 | +155.44% | 8 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $25.16 | +74.88% | 5 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $5.68 | +252.11% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $6 | $2.08 | +188.46% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $10.34 | +112.77% | 8 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $17.60 | +127.27% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $12 | $12.65 | -5.14% | 3 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $29 | $8.78 | +230.30% | 4 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | kr 33.00 | kr 10.26 | +221.64% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $13 | $4.35 | +198.85% | 9 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.57 | - | 4 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥1,130 | ¥304 | +271.71% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $49 | $23.32 | +110.12% | 3 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $250 | $251.65 | n/a | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $10.57 | n/a | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 → $103 | $152.67 | n/a | 35 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.92 | n/a | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $17 | $4.51 | n/a | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $51 | $98.35 | n/a | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $56 | $17.14 | n/a | 5 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $77 | $91.39 | n/a | 27 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $17 | $3.73 | n/a | 4 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $94 → $78 | $12.69 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $35 | $3.35 | n/a | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 | $122.06 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $518.83 | n/a | 6 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $5 | $11.69 | n/a | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $53.92 | n/a | 1 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $14.38 | n/a | 11 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $7.49 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $225.36 | n/a | 16 | Jul 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $59.03 | n/a | 12 | Jun 13, 2021 |
Opus Genetics
Sep 10, 2026
Reiterated: Buy
Price Target: $15
Current: $5.16
Upside: +190.70%
Pharvaris
Sep 9, 2026
Reiterated: Buy
Price Target: $46 → $65
Current: $35.20
Upside: +84.66%
Innoviva
Aug 20, 2026
Reiterated: Buy
Price Target: $34
Current: $20.98
Upside: +62.06%
EyePoint
Aug 17, 2026
Downgraded: Hold
Price Target: n/a
Current: $4.07
Upside: -
Belite Bio
Aug 14, 2026
Reiterated: Buy
Price Target: $266 → $270
Current: $175.35
Upside: +53.98%
Camp4 Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $7
Current: $4.15
Upside: +68.67%
Equillium
Aug 14, 2026
Reiterated: Buy
Price Target: $10
Current: $1.93
Upside: +418.13%
ProQR Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $8
Current: $1.90
Upside: +321.05%
Viking Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $100
Current: $40.85
Upside: +144.80%
Harrow
Aug 10, 2026
Reiterated: Buy
Price Target: $88
Current: $34.45
Upside: +155.44%
Aug 10, 2026
Reiterated: Buy
Price Target: $44
Current: $25.16
Upside: +74.88%
Aug 6, 2026
Reiterated: Buy
Price Target: $20
Current: $5.68
Upside: +252.11%
Aug 6, 2026
Reiterated: Buy
Price Target: $4 → $6
Current: $2.08
Upside: +188.46%
Aug 6, 2026
Reiterated: Buy
Price Target: $22
Current: $10.34
Upside: +112.77%
Aug 6, 2026
Reiterated: Buy
Price Target: $40
Current: $17.60
Upside: +127.27%
Aug 5, 2026
Reiterated: Buy
Price Target: $11 → $12
Current: $12.65
Upside: -5.14%
Jun 30, 2026
Reiterated: Buy
Price Target: $26 → $29
Current: $8.78
Upside: +230.30%
Jun 8, 2026
Initiated Coverage: Buy
Price Target: kr 33.00
Current: kr 10.26
Upside: +221.64%
May 18, 2026
Reiterated: Buy
Price Target: $34 → $13
Current: $4.35
Upside: +198.85%
Apr 1, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.57
Upside: -
Mar 17, 2026
Initiated Coverage: Buy
Price Target: ¥1,130
Current: ¥304
Upside: +271.71%
Feb 19, 2026
Reiterated: Buy
Price Target: $42 → $49
Current: $23.32
Upside: +110.12%
Apr 28, 2025
Initiated Coverage: Hold
Price Target: $250
Current: $251.65
Upside: n/a
Dec 11, 2024
Reiterated: Buy
Price Target: $22
Current: $10.57
Upside: n/a
Nov 8, 2024
Reiterated: Buy
Price Target: $93 → $103
Current: $152.67
Upside: n/a
Nov 4, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.92
Upside: n/a
May 10, 2024
Reiterated: Buy
Price Target: $22 → $17
Current: $4.51
Upside: n/a
Apr 18, 2024
Reiterated: Buy
Price Target: $24 → $51
Current: $98.35
Upside: n/a
Jan 3, 2024
Reiterated: Buy
Price Target: $27 → $56
Current: $17.14
Upside: n/a
Oct 18, 2023
Reiterated: Buy
Price Target: $84 → $77
Current: $91.39
Upside: n/a
Jun 23, 2023
Reiterated: Buy
Price Target: $25 → $17
Current: $3.73
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $94 → $78
Current: $12.69
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $33 → $35
Current: $3.35
Upside: n/a
May 4, 2023
Upgraded: Buy
Price Target: $38
Current: $122.06
Upside: n/a
Dec 19, 2022
Upgraded: Hold
Price Target: n/a
Current: $518.83
Upside: n/a
Dec 7, 2022
Reiterated: Buy
Price Target: $15 → $5
Current: $11.69
Upside: n/a
Nov 9, 2022
Reiterated: Buy
Price Target: $38
Current: $53.92
Upside: n/a
Aug 10, 2022
Downgraded: Sell
Price Target: n/a
Current: $14.38
Upside: n/a
Aug 6, 2021
Reiterated: Buy
Price Target: $18
Current: $7.49
Upside: n/a
Jul 22, 2021
Reiterated: Hold
Price Target: n/a
Current: $225.36
Upside: n/a
Jun 13, 2021
Reiterated: Sell
Price Target: n/a
Current: $59.03
Upside: n/a